Cost-Effectiveness Analysis of Sofosbuvir Plus Ribavirin in Patients With Genotype 2 Chronic Hepatitis C: An Analysis With Real World Outcomes From a Multicentre Cohort in Japan
BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-023405
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2019
Authors
Publisher
BMJ